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A B S T R A C T
Molecular epidemiology in human biomonitoring allows for verification of public exposure to chemical sub-
stances. Unfortunately, due to logistical difficulties and high cost, it evaluates only small study groups and as a
result does not provide comprehensive large scale community-wide exposure data. Wastewater fingerprinting
utilizing metabolic biomarkers of exposure that are excreted collectively by studied populations into urine and
ultimately into the community's wastewater, provides a timely alternative to traditional approaches. This study
aimed to provide comprehensive spatiotemporal community-wide exposure to bisphenol A (BPA, including BPA
intake) using wastewater fingerprinting. Wastewater fingerprinting was undertaken using high resolution mass
spectrometry retrospective data mining of characteristic BPA human metabolism marker (bisphenol A sulphate),
applied to a large geographical area of 2000 km2 and a population of ~1.5 million served by 5 WWTPs (was-
tewater treatment plants) accounting for> 75% of the overall population in the studied catchment. Community-
wide BPA intake was found to be below temporary tolerable daily intake (t-TDI) level of 4 μg kg−1 day−1 set by
the European Food Safety Agency (EFSA) suggesting overall low exposure at 3 WWTPs serving residential areas
with low industrial/commercial presence. However, at two WWTPs serving communities with higher industrial/
commercial presence, higher BPA sulphate loads corresponding to higher (up to 14 times) BPA intakes (ex-
ceeding 10 μg kg−1 day−1 at one WWTP and reaching 50 μg kg−1 day−1 at the second WWTP) were observed
and they are likely linked with occupational exposure. Characteristic temporal variations of BPA intake were
noted in most studied WWTPs with the lowest intake occurring during weekends and the highest during
weekdays.
1. Introduction
BPA belongs to the group of endocrine disruptors (EDCs). EDCs are
exogenous chemicals with the potential to interfere with the hormonal
regulation, hence with the endocrine system, consequently affecting
health and reproduction in animals and humans. In addition to devel-
opmental and reproductive effects, their potential for contributing to
metabolic disorders such as obesity is drawing more and more attention
(Casals-Casas and Desvergne, 2011). In the recent EU document ‘State of
the art assessment of endocrine disrupters’ (Kortenkamp et al., 2011) there
is an urgent call for new approaches to establish further evidence for
humans' exposure to EDCs, especially those chemicals which are still
not regulated (such as many suspected EDCs in personal care and
consumer products). Regulatory decisions about endocrine disruptors
will have to rely on weight-of-evidence procedures which are yet to be
established (Kortenkamp et al., 2011). It is therefore important to de-
velop new tools which will allow for long term real-time monitoring of
collective community-wide exposure to and effects from EDCs.
BPA is one of the most extensively studied EDCs because of its
ubiquity and its suspected effects including hormonal activity (BPA acts
as a weak oestrogen), effects on physical, neurological and behavioural
development and potential carcinogenicity (Joint Fao Oms Expert
Committee On Food Additives, 2010; Rochester, 2013). Because of a
lack of evidence, the EFSA (European Food Safety Agency) has tem-
porary lowered in 2015 the tolerable daily intake (TDI) from
50 μg kg−1 day−1 (set originally in 2006 by using the no observed ad-
verse effect level (NOAEL) of 5mg/kg/day and an uncertainty factor of
100) to temporary t-TDI of 4 μg kg−1 day−1 (until the outcome of a
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long-term study will help reducing uncertainties about potential health
effects (European Food Safety Authority (EFSA), 2015a). Even though
BPA is not intentionally added as ingredient to personal care products
or in the food production process, its presence might be due to migra-
tion from polycarbonate containers, epoxy resins coating or to the de-
gradation of the BPA-containing material (Hartle et al., 2016; Poustka
et al., 2007). Geens et al. (2012) summarised all the dietary (generally
considered to be the main source of BPA) and non-dietary exposure
pathways (e.g. dust, thermal paper, dental materials, etc.). Christensen
et al. (Christensen et al., 2012) concluded that the non-dietary exposure
to be one-third of the cohort median exposure. Currently, public ex-
posure to BPA is generally assessed using two approaches. The first one
entails the monitoring of concentrations of contaminants in exposure
media with exposure media contact rates (Lu et al., 2018). Interest-
ingly, the European Union (Aschberger et al., 2010) and EFSA
(European Food Safety Authority (EFSA), 2015b) found the dietary
intake to vary significantly with age, indicating major exposure risk for
infants (up to 13 μg kg−1 day−1) and 1.5 μg kg−1 day−1 for adults. The
second approach relies on human biomonitoring. This approach mea-
sures the concentration of BPA and metabolites in biological fluids to
back-calculate the overall exposure including both known and un-
known sources (Dekant and Völkel, 2008). However, the main limita-
tion of this approach, due to logistical difficulties and high cost, is the
restricted size of study groups and inability to gather comprehensive
information on the complexity of spatial and temporal exposure to BPA
(Bonassi and Au, 2002). Therefore, the community lacks robust mea-
sures that can be used to gather real-time information on community-
wide exposure to BPA.
Wastewater based epidemiology (WBE) utilizing water finger-
printing has the potential to overcome some of the above difficulties
and is able to assess both internal and external combined exposure to
EDCs. Exposure assessment can be undertaken through the analysis of
both parent EDCs and their metabolites in wastewater and in the en-
vironment. There are several points of verification. For example, the
presence of characteristic metabolites in wastewater is an indication
that EDCs have found their way into the body (internal exposure re-
sulting from e.g. consumption of EDCs with food, accidental ingestion
due to EDCs absorbed onto indoor dust, or absorption through skin of
EDCs used in PCPs) (Fig. 1).
The key concept of WBE is that human biotransformation products
of both endogenous or exogenous compounds resulting from exposure
to xenobiotic agents such as drugs, food toxicants and pollutants are
collected and pooled by the wastewater system, and are transported to
WWTPs, providing evidence of the extent of the exposure for the po-
pulation (Fig. 1). As WWTPs serve well-defined populations, estimation
of exposure to EDCs in a given period can be made based on the analysis
of wastewater (usually with sensitive and selective mass spectrometry
techniques) after taking into account human metabolism patterns (and
possible transformation in sewers) of target analytes. WBE is currently
utilised to determine community-wide illicit drug use (Ort et al., 2014;
Thomas et al., 2012; Castrignanò et al., 2018). Earlier work with
therapeutic drugs has demonstrated the close correspondence between
known amounts consumed by the population and the amounts esti-
mated from concentrations of metabolic drug residues in wastewater
(Heberer and Feldmann, 2005; Kasprzyk-Hordern et al., 2009) or in
surface waters (ter Laak et al., 2010). Table S1 gathers examples of WBE
application in public health and lifestyle assessment. For example, Ryu
et al. (2016) reported a Europe-wide monitoring of an oxidative stress
biomarker, 8-iso-PGF2α and found that increased levels of 8-iso-PGF2α
were observed at the inner-city level correlating with the degree of
urbanization and levels of nicotine use. Rousis et al. (2017) studied
community-wide exposure to pyrethroid pesticides in Italian cities.
(Gracia-Lor et al. (2017) undertook Europe-wide profiling of caffeine
use. Lopardo et al. (2017) identified new biomarkers of internal ex-
posure to endocrine disruptors. González-Mariño et al. (2017) in-
vestigated community-wide exposure to phthalate plasticizers in Spain.
This is the first study aimed to estimate community-wide exposure
to BPA (including BPA intake) using wastewater fingerprinting for BPA
sulphate, a metabolic biomarker of BPA intake. This study covers a
large geographical area of 2000 km2 (including several rural and urban
settlements) and a population of ~1.5 million accounting for> 75% of
the overall population in the studied catchment.
2. Experimental
2.1. Materials and chemicals
Bisphenol A sulphate (BPA sulphate, CAS 847696-37-1) was pur-
chased from Toronto Research chemicals (TRC, Canada) (Table S2). The
internal standards used were: 4-chloro-3-methylphenol-d2 (QMX (UK))
and BPA-d16 (Sigma-Aldrich (Gillingham, UK)). Water was purified
using a Milli-Q purification system from Millipore (Nottingham, UK).
Methanol, formic acid (> 95%), HCl (concentrated), 1M NaOH, 1M
NH4OH, NH4F, 2-propanol and bisphenol A (free BPA) were purchased
from Sigma (UK) and Fisher (UK). All solvents used were of LC grade or
higher. All the glassware was deactivated using 5% DMDCS (Sigma,
Fig. 1. Schematic representation of exposure to EDCs (BPA) in the household environment.
L. Lopardo et al. Environment International 125 (2019) 1–8
2
UK) to prevent losses from analyte adsorption. The deactivation pro-
cedure consisted of washing the glassware once with 5% DMDCS fol-
lowed by two washes with toluene and lastly three washes with me-
thanol.
2.2. Sampling and sample collection
Wastewater (untreated, after physical screening) was collected be-
tween June and October 2015 from 5 major WWTPs (Table 1) con-
tributing to one river catchment in the South-West UK and covering an
area of approximately 2000 km2 and the population of ~1.5 million
(this constitutes> 75% of the overall population in the catchment).
Wastewater was collected on 7 consecutive days at each WWTP as
volume proportional 24 h composites with sample collection fre-
quencies of 10min using ISCO 3700 portable samplers packed with ice
(RS Hydro, Worcestershire, UK) (Petrie et al., 2015). All samples were
transported on ice to the laboratory where they were frozen (−20 °C)
awaiting further processing.
2.3. Biomarker stability in wastewater
Biomarker stability in unfiltered wastewater was performed in PVC
bottles in aerobic conditions. Two wastewater aliquots were in-
vestigated in duplicate (4° and 17°) to simulate respectively sampler
and room temperature. Change in concentration was monitored over
24 h, which is the maximum period of time a sample can remain in the
sampler awaiting collection. Samples (100mL each) were taken at the
following interval times (0, 3, 12 and 24 h) and prepared for analysis as
described below.
2.4. Sample preparation and analysis
All samples were analysed with two analytical methods. Targeted
analysis of BPA was undertaken with UPLC-XevoTQD. Retrospective
identification and quantification of BPA sulphate was undertaken with
UHPLC-MaXis QTOF mass spectrometer. All details are provided below.
2.4.1. Analysis of free (unconjugated) BPA
Aqueous samples (50mL) were filtered using GF/F glass microfibre
filter 0.75 μm (Fisher Scientific, UK), adjusted to pH 7.5 ± 0.1 and
spiked with 50 ng of internal standard (50 μL of a 1 μgmL−1 methanolic
solution, BPA-D16) according to the procedure described by Petrie et al.
(Petrie et al., 2015). Solid phase extraction (SPE) was performed using
Oasis HLB sorbents (Waters, UK), which were conditioned using 2mL
MeOH followed by 2mL H2O at 1mLmin−1. Samples were then loaded
at 5mLmin−1 and dried under vacuum. Elution was performed using
4mL MeOH at a rate of 1mLmin−1. Methanolic extracts were subse-
quently dried under nitrogen using a TurboVap evaporator (Caliper,
UK, 40 °C, N2,< 5 psi). Dried extracts were reconstituted in 500 μL
80:20 H2O:MeOH ready for analysis.
Suspended particulate matter (SPM) and sludge samples were ob-
tained as a result of wastewater filtration through the GF/F filter.
Treated by using microwave assisted extraction (MAE) as described by
Petrie et al. (2015). Briefly samples were frozen, freeze-dried and 0.25 g
samples were spiked with 50 ng of BPA-D16. Extraction was achieved
by heating the samples at 110 °C using a 800W MARS 6 microwave
(CEM, UK) and 25mL of 50:50 MeOH:H2O (pH 2). MAE methanolic
extracts were adjusted to< 5% of MeOH using H2O (pH 2). SPE was
performed using Oasis MCX cartridges (Waters, UK) conditioned with
2mL MeOH followed by 2mL H2O (pH 2). Samples were loaded and
dried as described previously. Elution was performed using 2mL 0.6%
HCOOH in MeOH. Once dried, extracts were reconstituted in 500 μL
80:20 H2O:MeOH and filtered using pre-LCMS 0.2 μm PTFE filters
(Whatman, Puradisc).
Analysis of all samples was undertaken using a Waters Acquity
UPLC system (Waters, Manchester, UK) coupled with a Xevo TQD Triple
Quadrupole Mass Spectrometer (Waters, Manchester, UK). A reversed-
phase BEH C18 column (150×1.0mm, 1.7 μm particle size) (Waters,
Manchester, UK) was used with a 0.2 μm, 2.1mm in-line column filter.
Separation of analytes was achieved using 80:20 H2O:MeOH mobile
phase containing 1mM NH4F (mobile phase A) and 5:95 H2O:MeOH
also containing 1mM NH4F (mobile phase B) at 25 °C and flow rate of
0.04mLmin−1. Mobile phase gradient was as follows: starting condi-
tions: 100% A maintained for 0.5 min, reduced to 40% A over 2min and
to 0% A over a further 5.5min and then maintained for 6min before
returning to starting conditions (maintained for further 8.4 min to allow
re-equilibration; total run time was 22.5 min). The injection volume
was 15 μL. The Xevo TQD Triple Quadrupole Mass Spectrometer was
equipped with an electrospray ionisation source. Nitrogen was used as
the nebulising and desolvation gas, and argon as the collision gas.
Analysis was performed in negative ionisation mode with a capillary
voltage of 3.20 kV, the desolvation temperature of 400 °C and the
source temperature of 150 °C. The cone gas flow was 100 L h−1and the
desolvation gas flow was 550 L h−1. The multiple reaction monitoring
(MRM) transitions for BPA were 227.3 > 212.1m/z (quantifier, 22 eV
collision energy) and 227.3 > 132.7m/z (qualifier, 25 eV collision
energy). The MRM transition for BPA-D16 was 241.1 > 223.1 m/z
(20 eV collision energy). The cone voltage for both BPA and BPA-D16
was 40 V. Detailed discussion regarding the method and its perfor-
mance can be found elsewhere (Petrie et al., 2015) and in Tables
S3A–S5A.
2.4.2. Analysis of BPA sulphate
Liquid samples were spiked with internal standard (25 μL of a so-
lution 1 μgmL−1) and filtered using GF/F glass microfibre filter
0.75 μm (Fisher Scientific, UK) and solid phase extraction (SPE) was
performed using Oasis HLB (Waters, UK) according to the procedure
described elsewhere (Lopardo et al., n.d.) and above (Section 2.4.1).
The SPE extraction recovery was evaluated at two different con-
centrations in duplicate.
Samples were analysed using Dionex Ultimate 3000 HPLC coupled
with a Bruker Maxis HD Q-TOF according to (Lopardo et al., n.d.).
Briefly, a multi-step gradient was used to separate the analytes at a flow
rate of 0.4mLmin−1 on a BEH C18 column (50× 2.1mm, 1.7 μM,
Waters UK) using mobile phase A (1mM ammonium fluoride in water)
and mobile phase B (methanol). The mass spectrometer was equipped
with an ESI source and was operated in both positive and negative io-
nisation mode. The source settings were as follows: capillary voltage
was set at 4.5 kV, the end plate offset was set to 500 V, a pressure of 3
Bar was used for the nebulizer gas, the drying gas (nitrogen) flow was
Table 1
Information about WWTPs investigated.
Site A B C D E
Sewer residence timea (h) < 0.5–4 <0.5–4 <0.5–9 <0.5–2 <1–24
Population served 37,000 67,870 105,847 17,638 909,617
Industrial contribution (%) < 1 19 1 <1 5
Mean flow (m3 d−1) 8242 ± 3085 11,202 ± 3202 24,875 ± 2167 2924 ± 199 153,061 ± 12,245
a Under summer (dry weather) flow.
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11 Lmin−1 and the drying temperature was set at 220 °C. Analysis was
run in both full scan mode (MS) and broadband collision induced dis-
sociation (bbCID) mode. Calibrant solution was injected before each
run. Quality control samples were run every 10 samples. For details see
(Lopardo et al., n.d.) and Table S3B.
BPA sulphate was identified using post-acquisition data mining of
analysed wastewater samples as discussed in Lopardo et al. (2018).
Commercially available BPA sulphate standard was used to confirm the
presence of BPA sulphate in wastewater samples as well as to establish a
calibration curve for subsequent quantification of BPA sulphate. 4-
chloro-3-methylphenol-d2, already present in analysed samples, was
used as an internal standard for BPA-sulphate quantification.
Method performance was verified as follows. Linearity was estab-
lished by triplicate injection of a 13-point calibration curve ranging in
concentration from 0.01 to 100 ngmL−1. Instrumental detection limits
(IDLs) and instrument quantitation limits (IQLs) were calculated ac-
cording to the lowest concentration which gave a signal to noise ratio of
≥3 and ≥10 respectively. Recovery of target chemicals was de-
termined by spiking crude wastewater at a concentration of 4 and
50 ng L−1. BPA and BPA sulphate validation parameters are listed in
Tables S4B and S5B.
2.5. Daily mass loads and BPA intake
Daily mass loads of BPA sulphate (mg day−1) were calculated by
multiplying the concentrations (mg L−1) found in a 24 h composite raw
wastewater sample by the daily wastewater flow rate (L day−1). Total
free BPA concentrations in raw wastewater were calculated after taking
into account both the amount of free BPA adsorbed onto solid parti-
culate matter (SPM) and the amount present in the liquid fraction. Mass
loads (mg day−1) were then normalised to the number of people served
by each WWTP (mg day−1 1000 inhabitants−1), in order to compare
results between different WWTPs. Population-wide BPA intakes
(mg day−1 1000 inh−1) were calculated using the following equation:
=
− −BPA mg day inh conc x V x CF
P
[ 1000 ] ( . )intake 1 1
where: conc. is the concentration of BPA sulphate (mg L−1) in influent
wastewater, V is the volume of wastewater received by the WWTP per
day (L day−1), P stands for the population served by the WWTP and CF
is the correction factor. CF was calculated taking into account the
molecular mass ratio between free BPA and BPA sulphate and BPA
sulphate excretion ratio. There are published studies that have in-
vestigated the presence of BPA sulphate in urine. Three papers were
considered in this study. Ye et al. (2005) found that BPA sulphate re-
presented 21% of BPA metabolites in urine (n=30). Ho et al. (2017)
analysed 140 urine samples finding that BPA sulphate represented
6.25% of BPA metabolites. Thayer et al. (Thayer et al., 2015) instead
observed that only 3% of the total BPA-d6 ingested by 14 volunteers
was excreted in urine as BPA sulphate and that the total administered
dose recovered in urine was 84–109%, with> 90% of BPA-d6 excreted
as metabolites within 24 h from consumption. Study by Thayer et al.
(2015) is the only one providing truly representative excretion factors.
However, it focussed on a very limited dataset (only 14 volunteers
contributed). CF for BPA sulphate was therefore calculated as 0.16,
using 8.41% as BPA sulphate excretion factor (weighed mean of the
percentage of BPA sulphate excreted against the number of urine
samples in all three studies). However, as we acknowledge un-
certainties linked with studies by Ye et al. (2005) and Ho et al. (2017),
we also calculated daily intake using CF of 0.45 corresponding with 3%
excretion as reported by Thayer et al. (Thayer et al., 2015) only.Po-
pulation-wide BPA intakes were then normalised to the weighted mean
of the population weight (mg/ kg day−1) using the following formula:
=
− −
− −
BPA mg kg day BPA mg day inh[ ] [ 1000 ]
56.3intake
intake1 1
1 1
where 56.3 is the weighted mean of the UK population weight in kg
after taking into account as follows: 4.5 kg for babies at 1–2months,
7 kg for babies at 4–6months, 11 kg for children 1.5–4.5 years old, and
60 kg for adults (Mørck, 2011). Percentage of people n years old in the
UK was sourced from UK Office for National Statistics (ONS).
Daily BPA intake was evaluated for weekdays (Tuesday-Friday) and
weekends (Sat-Sun). Monday measurements were not taken into ac-
count in weekday vs. weekend comparison due to metabolism of BPA
requiring up to 24 h after exposure for metabolite excretion in urine
(Thayer et al., 2015). Statistical analysis was undertaken using F-Test
Two-Sample for Variances followed by either t-Test: Two-Sample As-
suming Equal Variances or t-Test: Two-Sample Assuming Unequal
Variances.
3. Results and discussion
3.1. BPA sulphate as a biomarker of BPA intake
Based on our previous work (Lopardo et al., 2018), BPA sulphate
was selected as a characteristic metabolic biomarker of human internal
exposure to BPA. A literature search revealed no known non-metabolic
sources of BPA sulphate in the environment. Analysis of solid and liquid
fractions of wastewater collected from an activated sludge tank re-
vealed that only a minor fraction of BPA sulphate adsorbs onto solid
matter (< 7%), which indicates that the analysis of only aqueous
fraction of wastewater for BPA sulphate is required in order to estimate
BPA intake. Low sorption of BPA sulphate was expected given the
greater hydrophilicity of BPA sulphate compared to free (unconjugated)
BPA. However, to ensure high accuracy of measurements, internal
standards were added to wastewater samples before filtration through
GF/F filters, which is in the presence of suspended particulate matter
(SPM), in order to correct for possible sorption of analytes to SPM. In
addition, a study of BPA sulphate stability confirmed its high stability in
wastewater over 24 h sampling time at 4 °C (Fig. S1), validating its
applicability as a biomarker of public BPA exposure via wastewater
fingerprinting.
3.2. Daily mass loads of free BPA and BPA sulphate in wastewater
Free BPA and BPA sulphate were identified and quantified (Table
S6) in all collected samples (Fig. 2 and Table 1). BPA sulphate was
found at higher concentrations than free BPA. This is, as discussed
above, due to extensive metabolism of BPA which leads to excretion of
BPA mostly as conjugated metabolic residues. Its total concentrations
ranged from 0.7 to 1.5 μg L−1 for WWTPs A, C and D and from 1.5 to
60 μg L−1 for WWTPs B and E. Concentrations of free BPA ranged from
0.5 to 0.9 μg L−1 in WWTPs A and C, while in WWTPs B, D and E they
ranged from 1.3 to 100 μg L−1. Recorded SPM concentrations ranged
from 0.03 to 0.27 μg g−1 in WWTPs A, C and D while in WWTPs B, and
E they ranged from 0.1 to 15 μg g−1.
Due to sampling being conducted in WWTPs located in 5 different
geographical locations (Fig. 2) within the same river catchment, con-
siderable spatial variability in daily free BPA and BPA sulphate loads
could be observed, and because sampling at each WWTP was operated
over 7 consecutive days (Wednesday to Tuesday), it was possible to
gather information about both spatial and temporal variability for a full
week.
Free BPA loads ranged from 179 to 597mg day−1 1000 inh−1 at
WWTPs A, C and D. Statistical analysis revealed that temporal (week vs
weekend) free BPA changes at these WWTPs are not statistically sig-
nificant (p=0.2897, 0.2737 and 0.3639 for WWTPs A, C and D re-
spectively). At WWTP E, free BPA loads were on average two orders of
magnitude greater during weekdays when compared to weekends.
Weekday vs. weekend loads denoted 9897 and 1517mg day−1
1000 inh−1 respectively (p=0.0452). WWTP B showed the greatest,
statistically significant (p= 0.0325), variability with free BPA loads
L. Lopardo et al. Environment International 125 (2019) 1–8
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averaging at 3913mg day−1 1000 inh−1 during weekday and
539mg day−1 1000 inh−1 during weekend (Fig. 3). These loads cor-
respond to concentrations of free BPA in wastewater up to 100 μg L−1
which is considerably more than what is generally observed since free
BPA can be usually found in urban wastewater at concentrations around
1 μg L−1. The reason why such high concentrations of free BPA were
observed at WWTPs B and E might be the contribution of industrial
wastewater as suggested by Petrie et al. (Petrie et al., 2019). Higher free
BPA loads were in fact observed downstream from a paper producing
plant from Fuerhacker in 2003 (Fuerhacker, 2003). As expected, high
loads of free BPA at WWTPs B and E corresponded, due to elevated
exposure, with high loads of BPA sulphate as discussed below (Fig. 3).
BPA sulphate loads ranged from 147 to 916mg day−1 1000 inh−1 at
WWTPs A, C and D (Fig. 3) whereas average loads at WWTPs B and E
were an order of magnitude greater (from 495 to 17,003mg/day
1000 inh−1, Fig. 3). BPA sulphate loads recorded during weekly sam-
pling campaigns were relatively constant (RSD %≤ 40%) at WWTP A
and C (Fig. 3, p= 0.2931 and 0.4266 respectively). On the other hand,
statistically significant temporal BPA sulphate loads variability was
observed at WWTPs D and E (RSD%≥50%, 0.0140 and 0.0160 for
WWTPs D and E respectively), indicating generally lower exposure
during weekends compared to weekdays (Fig. 3). WWTP B showed the
greatest variability in BPA sulphate due to loads being more than an
order of magnitude greater on two weekdays. However, the weekday
pattern vs weekend was found to be irregular and statistically insig-
nificant (p=0.0746), possibly due to accidental release of free BPA
leading to elevated exposure levels on two weekdays only, as explained
later.
3.3. Estimation of public BPA intake via wastewater fingerprinting
The community-wide BPA intake (internal exposure) was estimated
using the WBE approach as described in the Experimental section.
Calculated loads of BPA sulphate at WWTPs A, C and D corresponded to
an estimated BPA intake (Fig. 3 and Table S8) which was consistently
below TDI level set by EFSA (at 4 μg kg−1 day−1) suggesting overall
low exposure.
Weekly average population A, C and D intake was consistent and
accounted for: 1.9, 1.8 and 1.3 μg kg−1 day−1 respectively which is in
line, albeit at the higher end, with published literature focussing on
estimated BPA intake through dietary exposure, e.g.
0.08–1.5 μg kg−1 day−1 (NTP, 2008), indicating other exposure
sources. On the other hand, WWTPs B and E were characterised by
higher loads corresponding to higher, up to 14 times, intakes that were
above the TDI threshold for several days during the sampling period.
WWTP B results (48 μg kg−1 day−1 intake on Wednesday) indicate that
accidental release of free BPA linked with elevated exposure occurred
on or just before Wednesday. Interestingly, WWTP E shows overall high
exposure (on average exceeding 10 μg kg−1 day−1), possibly as a result
of occupational exposure.
Diet is considered the primary source of exposure to BPA for the
general population (NTP, 2008), although non-dietary contributions
should not be ignored as they can provide a significant contribution to
the overall daily intake, e.g. infant and child exposure can reach
14 μg kg−1 day−1, and occupational exposure could be as high as
100 μg kg−1 day−1 as reported by NTP in powder paint workers (NTP,
2008). Indeed, it can be seen from Table 1 that WWTPs A, C and D serve
smaller, more residential communities and receive very low industry
derived wastewater accounting for ≤1%. This could explain lower
daily loads of both free BPA and BPA sulphate. On the other hand,
WWTP B and E have higher contribution from industrial wastewater
accounting for 19 and 5%. Additionally, WWP E is a large treatment
works serving almost 1mln people. Higher free BPA levels and resultant
higher exposure and high free BPA loads were therefore expected in the
communities served by WWTP B and E.
It is also interesting to note that characteristic temporal variations
of BPA intake were observed in three out of five studied WWTPs,
namely WWTP B, D and E with the lowest intake occurring during
weekends and the highest during weekdays. Population B served by
WWTP B showed average intake on Wed–Thur denoting
38.5 μg kg−1 day−1 and only 1.4 μg kg−1 day−1 on Sat–Sun
(p= 0.0745). Population E served by WWTP E showed statistically
significant increase in intake during weekdays averaging at
17.7 μg kg−1 day−1 when compared to average weekend intake of
5.4 μg kg−1 day−1 (p=0.0160). A similar pattern was observed in
WWTP D with average BPA intake accounting for 2.1 μg kg−1 day−1
during weekdays and only 0.4 μg kg−1 day−1 during weekend
(p= 0.0181). The population contributing to WWTP A and C showed
much lower, or no significant difference in BPA intake (WWTP A: 1.7 vs
1.6 μg kg−1 day−1, p= 0.2447 and WWTP C: 1.7 vs 1.7 μg kg−1 day−1,
p= 0.4265). This is an important observation indicating that public
exposure to BPA is much higher during working days. There are several
possible reasons for this including healthier diet during weekends vs
higher exposure of workers in industrial settings during weekdays.
Indeed, temporal variation in BPA exposure in sites B and E confirms
yet again our hypothesis that higher levels of BPA intake in these lo-
cations are due to occupational exposure.
The above results indicate that only under certain scenarios daily
BPA intake exceeds EFSA TDI levels. However, one needs to note that in
this manuscript weighted mean average excretion values sourced from
Fig. 2. Studied catchment area and 5 major WWTPs serving 5 cities.
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all three published studies on BPA sulphate biomonitoring were used
(Ye et al., 2005) (Ho et al., 2017) (Thayer et al., 2015). These studies
reported different BPA sulphate excretion levels ranging from 21%
(n=30) (Ye et al., 2005) and 6.25% (n= 140) (Ho et al., 2017) to only
3% (n=14) (Thayer et al., 2015). It is also important to note that only
Thayer et al. (2015) undertook metabolite profiling after administration
of BPA-d6. The other two studies focussed on the analysis of a large
pool of urine samples without providing any knowledge of actual ex-
posure levels and therefore probably overestimated the percentage of
BPA sulphate excretion. In order to understand uncertainties of our
calculations, we also calculated daily BPA intake using only 3% ex-
cretion (CF factor of 0.45). The results are presented in Table S7. The
results clearly indicate significantly elevated BPA exposure levels
exceeding the safe TDI level of 4 μg kg−1 day−1. Such a result is con-
cerning and warrants further study which will be undertaken in due
course mainly in the context of refining CF values followed by a larger
scale human biomonitoring study.
3.4. Cumulative BPA loads versus daily BPA intake
Thayer et al. (2015) reported in the most recent study on BPA
metabolism in 14 volunteers using BPA-d6 (to eliminate other sources
of BPA than consumed for the study) that 95% ± 7.1% of total BPA-d6
(dose administered) was excreted in urine in 24 h with only
0.11% ± 0.19% (of total d6-BPA) as unconjugated d6-BPA and the
remaining dose as conjugated dBPA: 87% ± 6.9% as BPA-d6
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glucuronide and 3 ± 2.3 as BPA-d6 sulphate. In this study we used
8.41% as BPA sulphate excretion factor (based on weighed mean of the
percentage of BPA sulphated excreted against the number of urine
samples in the different studies) (see Section 2.5). Therefore, it could be
assumed that only a small fraction (< 1%) of the total BPA load would
be present in wastewater as free BPA with<10% as BPA sulphate
and > 90% as BPA glucuronide. BPA glucuronide was not measured in
this study neither was hydrolysis of BPA glucuronide undertaken during
sample preparation. As can be seen in Fig. 4, free BPA constitutes larger
percentage of the overall BPA load than expected from metabolism
studies. There are two main reasons for this: (1) direct disposal of un-
consumed BPA leading to increased loads of free BPA, (2) possible
cleavage of free BPA from BPA glucuronide due to microbial hydrolysis
in wastewater; this aspect will require further studies. Interestingly,
comparison of population normalised daily free BPA loads (accounting
for liquid and solid particulate matter) and BPA sulphate loads revealed
that, despite higher levels of free BPA than expected due to metabolism
only, the presence of free BPA corresponds to its actual intake (measure
via BPA sulphate). For example, as can be seen in Fig. 4, average weekly
loads of BPA are higher in WWTP B and E than WWTP A, C and D. This
is also the case with BPA sulphate loads. Interestingly, higher external
exposure and subsequent intake in populations B and E, is likely linked
with higher industrial wastewater contribution at WWTPs B and E.
WWTP B receives the highest contribution reaching 19%, including
food manufacture, toiletry manufacture and paint stripping (Table 1).
Site E receives 5% of its wastewater from several industrial contributors
including commercial laundrette, food manufacturing and vehicle
washing, packaging industry, food warehousing and distribution.
Overall, site B, as the most industrialised of all five sites studied, in-
dicates, yet again, the highest public exposure to BPA and is likely
linked with occupational exposure. This indicates that both free BPA
and BPA sulphate could serve as good indicators of intake. Simply, the
higher the external exposure (free BPA) the higher the intake (BPA
sulphate).
This study reports the strong potential of using wastewater finger-
printing as a tool to estimate public exposure to industry and household
derived chemicals with the aim of evaluating community-wide risks,
verifying spatiotemporal trends in exposure and indicate possible
sources of exposure (e.g. link occupational exposure with industrial
activity in the studied area). This cannot be currently achieved with the
available epidemiology, risk assessment and human biomonitoring
tools due to their limitations including: small study groups resulting
from the high cost of biomonitoring and significant lag time in ob-
taining data. On the other hand, the main limitation of this approach is
that it cannot, and it is not intended to, estimate individual exposure to
chemicals for example in children vs adults or man vs woman. It can
however provide estimates at a community level, and as a result, is has
the potential to become a powerful tool for large scale screening studies
identifying communities at risk and leading to further more compre-
hensive work of at a more localised scale.
4. Conclusions
This study has provided the first comprehensive spatiotemporal
community-wide exposure assessment to BPA (including BPA intake)
using wastewater fingerprinting. This study was also the first to verify
spatiotemporal changes in BPA intake including occupational exposure.
Community-wide BPA intake was found to be on average
1.6 μg kg−1 day−1 in more residential areas (WWTPs A, C and D) with
low industrial contribution, which is consistently below the t-TDI level
set by EFSA (at 4 μg kg−1 day−1), and suggesting overall low exposure
in these locations. However, at two WWTPs (B and E), higher BPA
sulphate loads corresponding to higher intakes (exceeding
10 μg kg−1 day−1 in the population served by WWTP E and reaching
50 μg kg−1 day−1 in the population served by at WWTP B), that were
well above (up to 14 times higher) the TDI threshold were observed and
they are likely linked with occupational exposure. Characteristic tem-
poral variations of BPA intake were observed in WWTPs B, D and E with
the lowest intake occurring during weekends and the highest during
weekdays. This is an important observation indicating that public ex-
posure to BPA is much higher during working days. There are several
possible reasons for this including healthier diet during weekends vs
higher exposure of workers in industrial settings during weekdays
(especially in more industrialised communities' B and E). Further work
will need to be undertaken to fully understand sources of free BPA and
BPA sulphate that might be contributing to the biomarker concentra-
tion levels in the studied catchment. Furthermore, additional studies
are required to fully understand human metabolism of BPA with the
aim of providing a robust correction factor for BPA intake calculation.
Finally, better tools for estimating population size are critically needed
to reduce uncertainties linked with population size/movement in stu-
died catchment areas.
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Table S1. WBE for public health and lifestyle assessment  
Compounds Biomarker Health status - comments References 
Illicit and abused drugs 
 
Drugs and urinary 
metabolites 
Enantiomeric enrichment 
Lifestyle 
(Andrés-Costa et al., 
2017; Castrignanò et 
al., 2018, 2017; Jones 
et al., 2014; Kasprzyk-
Hordern et al., 2008; 
van Nuijs et al., 2011) 
Alcohol 
Ethyl sulphate, 
Isoxanthohumol, Resveratrol 
Metabolites 
Lifestyle (Reid et al., 2011)(Ryu et al., 2016a) 
Caffeine 
1-methylxanthine, 7- 
methylxanthine 
Lifestyle/population 
biomarker 
(Gracia-Lor et al., 
2017; Senta et al., 
2015) 
Tobacco 
cotinine, tobacco specific 
nitrosamines, menthol, 8-iso-
prostaglandin F2α 
Lifestyle (Lai et al., 2017)(Ryu et al., 2016b) 
Pharmaceuticals 
Specific pharmaceuticals and 
their metabolites 
Enantiomeric enrichment 
Health 
(Camacho-Muñoz et 
al., 2016; Jones et al., 
2014; Kasprzyk-
Hordern et al., 2008; 
Petrie et al., 2015) 
Endocrine disruptors Urinary metabolites Health  (Lopardo et al., 2018) 
Pesticides 
Specific pesticides and their 
metabolites 
Enantiomeric enrichment 
Health (Rousis et al., 2017a, 2017b, 2016) 
Phthalates Urinary metabolites Health 
(Andrés-Costa et al., 
2017; Castrignanò et 
al., 2018, 2017; Jones 
et al., 2014; Kasprzyk-
Hordern et al., 2008; 
van Nuijs et al., 2011) 
Oxidative stress 8-iso-prostaglandin F2alpha Health (Reid et al., 2011)(Ryu et al., 2016a) 
Cancer mtDNA Health 
(Gracia-Lor et al., 
2017; Senta et al., 
2015) 
 
Table S2 General information about BPA and BPA sulphate 
 
Table S3A UHPLC-QqQ parameters used in the determination of BPA  
Chemical CAS number Molecular 
Weight 
Log Kow Formula Structure 
Bisphenol A 80-05-7 228.3 
3.32 
C15H16O2 
OHHO  
Bisphenol A 
sulphate  
 
847696-37-1 308.1  C15H16O5S 
OHO
S
O
O
OH
 
Chemical Rt  
(min) 
Precursor 
ion 
Product 
ion 1 
CV(V)/ 
CE(eV) 
Product 
ion 2 
CV(V)/ 
CE(eV) 
Ion ratio Internal 
standard 
Bisphenol 
A sulphate 
8.96 227.3 212.1 40/22 132.7 40/25 1.60±0.08 Bisphenol 
A-D16 
Table S3B UHPLC-QTOF parameters used in the determination of BPA sulphate 
 
 
Table S4A UHPLC-QqQ instrument performance parameters 
Analyte IS Linearity Range 
[µg L-1] 
R2 Accuracy* 
[%] 
Precision* 
[%] 
IDL 
[µg L-1] 
IQL 
[µg L-1] 
Bisphenol A Bisphenol A-
D16 
0.1-600 0.997 104.6 1.3 0.03 0.10 
*concentration levels: 10,100, 500 ng/mL used for precision and accuracy 
 
Table S4B UHPLC-QTOF instrument performance parameters 
Analyte IS Linearity Range 
[µg L-1] 
R2 Accuracy* 
[%] 
Precision* 
[%] 
IDL 
[µg L-1] 
IQL 
[µg L-1] 
Bisphenol A 
Sulphate 
4-chloro-3-
methylphenol-D2 
1.39 - 103.4 0.9972 98.3 2.1 0.41 1.39 
*concentration levels: 0.1, 5 and 100 ng/mL used for precision and accuracy 
 
Table S5A SPE-UHPLC-QqQ and MAE-SPE-UHPLC-QqQ method performance parameters 
Analyte Wastewater  SPM/Sludge 
 SPE recovery 
[%]* 
MDL 
[ng L-1] 
MQL  
[ng L-1] 
MAE 
recovery 
[%]* 
MDL 
[ng g-1] 
MQL  
[ng g-1] 
BPA 112.2 0.85 2.79 95.7 0.27 0.88 
* concentration levels: 100, 1000 ng/L and  50, 100 ng/g used for SPE and MAE recovery 
 
Table S5B SPE-UHPLC-QTOF method performance parameters 
Analyte Wastewater  
 SPE recovery 
[%]* 
MDL 
[ng L-1] 
MQL  
[ng L-1] 
BPA sulphate 63.7±6.3 1.6 5.5 
* based on duplicate extractions at two concentration levels 
 
 
 
 
 
 
 
 
Chemical Rt  
(min) 
m/z 
[M-H]- 
Mass 
error 
(ppm) 
bbCID Fragment Structure 
Bisphenol A 
sulphate 
6.8 307.0646 <10 307.0646 > 227.1078 
OHO
S
O
O
O
227.1078  
Table S6 BPA and BPA sulphate concentrations in wastewater (weekly averages and daily 
means). 
Analyte   Concentration 
   WWTPA WWTPB WWTPC WWTP D WWTP E 
BPA  Weekly 
average 
Aqueous 
[µg L-1] 
0.2±0.06 1.5±1.3 0.1±0.07 0.4±0.6 6.2±5.3 
SPM  
[µg g-1] 
0.9±0.2 20.4±15.7 0.98±0.1 1.7±0.2 37.2±29.3 
Wed Aqueous 
 [µg L-1] 
1.3 41.2 1.0 
 
1.6 51.9 
SPM  
[µg g-1] 
0.3 3.6 0.2 0.1 7.8 
Thu Aqueous 
 [µg L-1] 
1.1 27.0 1.0 
 
2.0 99.3 
SPM  
[µg g-1] 
0.21 2.22 0.12 0.2 15.5 
Fri Aqueous 
 [µg L-1] 
0.9 29.7 1 1.62 19.41 
SPM  
[µg g-1] 
0.2 2.3 0.1 1.9 0.2 
Sat Aqueous 
 [µg L-1] 
0.9 3.6 1.2 
 
1.9 8.6 
SPM  
[µg g-1] 
0.2 0.3 0.3 0.1 1.1 
Sun Aqueous 
 [µg L-1] 
0.8 2.8 1.1 1.4 8.6 
SPM  
[µg g-1] 
0.2 1.5 0.03 0.1 1 
Mon Aqueous 
 [µg L-1] 
0.5 36.2 0.9 
 
1.8 36.8 
SPM  
[µg g-1] 
0.1 0.1 0.1 0.1 9.9 
Tue Aqueous 
 [µg L-1] 
0.6 2.3 0.8 
 
1.4 35.5 
SPM  
[µg g-1] 
0.1 0.1 0.1 0.1 7.2 
BPA 
sulphate 
Weekly 
average 
Total  
[µg L-1] 
3.1±1.2 32.4±42.5 2.7±0.4 2.8±1.8   28.0±13.8 
Wed Total  
[µg L-1] 3.1 121.1 2.9 6.0 38.4 
Thu Total  
[µg L-1] 3.8 70.3 2.2 3.6 53.0 
Fri Total  
[µg L-1] 5.1 17.0 2.6 2.2 23.8 
Sat Total  
[µg L-1] 3.3 3.5 3.1 0.7 6.5 
Sun Total  
[µg L-1] 2.7 4.0 2.3 0.8 17.5 
Mon Total  
[µg L-1] 1.1 6.9 3.1 2.9 27.8 
Tue Total  
[µg L-1] 2.3 3.9 2.5 2.8 28.8 
 
  
Table S7 Estimated BPA intake using a correction factor (CF) of 0.45 based only on Thayer 
et al. BPA sulphate excretion percentage  (Thayer et al., 2015). 
BP
A
 in
ta
ke
 
 
(µ
g/
da
y/
kg
) 
 WWTP A WWTP B WWTP C WWTP D WWTP E 
Wed 5.43±0.5 157.56±16 5.36±0.5 8.05±0.8 50.94±6 
Thu 6.82±0.6 91.44±9.1 4.14±0.4 4.82±0.5 70.24±7 
Fri 9.16±0.9 22.13±2.2 4.95±0.5 2.90±0.3 31.49±3.1 
Sat 5.90±0.6 4.57±0.5 5.79±0.6 0.97±0.1 8.59±0.9 
Sun 4.87±0.5 5.22±0.5 4.33±0.4 1.10±0.1 23.19±2.3 
Mon 1.94±0.2 9.00±0.9 5.73±0.6 3.86±0.4 36.79±3.6 
Tue 4.06±0.4 5.08±0.5 4.75±0.5 3.71±0.4 38.17±3.8 
 
Table S8 Estimated BPA intake using a correction factor (CF) of 0.16 based on Thayer et al.; 
Ho et al.; and Ye et al., BPA sulphate excretion percentage (Thayer et al., 2015); (Ho et al., 
2017); (Ye et al., 2005). 
BP
A
 in
ta
ke
 
 
(µ
g/
da
y/
kg
) 
 WWTP A WWTP B WWTP C WWTP D WWTP E 
Wed 1.94±0.2 46.27±5.6 1.92±0.2 2.87±0.3 18.19±1.8 
Thu 2.43±0.2 30.66±3.1 1.48±0.1 2.67±0.3 25.08±2.5 
Fri 3.27±0.3 7.90±0.8 1.77±0.2 1.72±0.2 11.25±1.1 
Sat 2.11±0.2 1.63±0.2 2.07±0.2 0.35±0.03 3.07±0.3 
Sun 1.74±0.2 1.86±0.2 1.55±0.2 0.39±0.04 8.28±0.8 
Mon 0.69±0.7 3.21±0.3 2.05±0.2 1.38±0.1 14.14±1.4 
Tue 1.45±0.1 1.81±0.2 1.70±0.2 1.33±0.1 13.63±1.3 
  
 
Figure S2 BPA and BPA sulphate concentration change over a 24h stability study 
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